Tower Research Capital LLC (TRC)
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1533421
NEW YORK, NY
Position in CRNX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$145,750
-$99,590 QoQ
Shares Held
3,895
-42.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#191
of 266 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. CRNX ranks #63 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in CRNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $145,750 | 3,895 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $245,340 | 6,755 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $285,025 | 6,123 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $119,119 | 2,860 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $367,207 | 12,768 | Shares | Other | 2025-08-15 | |
| 2025-03-31 | $17,876 | 533 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $378,974 | 7,412 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $23,097 | 452 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $575,820 | 12,856 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $26,915 | 575 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $128,194 | 3,603 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $46,512 | 1,564 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $81,882 | 4,544 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $29,166 | 1,927 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $16,799 | 918 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $200,111 | 10,189 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $83,962 | 4,502 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $367,530 | 16,744 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $99,946 | 3,518 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $79,253 | 3,765 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $35,513 | 1,884 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $9,947 | 651 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $85,690 | 6,073 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $358,592 | 22,884 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $57,851 | 3,302 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||